<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>19</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>In Silico Docking Studies of Selected Flavonoids - Natural Healing Agents against Breast Cancer</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>8155</FirstPage>
			<LastPage>8159</LastPage>
			<ELocationID EIdType="pii">29895</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; Breast cancer is the serious health concern in India causing the highest mortality rate infemales, which occurs due to uncontrolled cell division and can be metastasize to other parts of the humanbody. Interactions with estrogen receptor (ER) alpha are mainly responsible for the malignant tumors withregulation of the transcription of various genes as a transcription factor. Most of the drugs currently used forthe breast cancer treatment produce various side effects and hence we focused on natural compounds whichdo not exhibit any toxic effect against normal human cells. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Structure of human ERwas retrieved from the Protein Data Bank and the structures of flavonoid compounds have been collected fromPubChem database. Molecular docking and drug likeness studies were performed for those natural compoundsto evaluate and analyze the anti-breast cancer activity. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Finally two compounds satisfying the Lipinski’srule of five were reported. The two compounds also exhibited highest binding affinity with human ER greaterthan 10.5 Kcal/mol. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: The results of this study can be implemented in the drug designing pipeline.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Flavonoids</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">human estrogen receptor</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">argus lab</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Docking</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_29895_f688c54d0135d007191f68c23d2eef08.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
